Mode
Text Size
Log in / Sign up

Network meta-analysis of nurse-implementable sedation strategies in mechanically ventilated adultsNurse-led sedation strategies improve outcomes for ventilated ICU patients

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider protocolised sedation and daily sedation interruption as nurse-implementable strategies to increase ventilator-free days in mechanically ventilated adults.

This is a systematic review and network meta-analysis of randomized trials evaluating nurse-implementable sedation strategies for mechanically ventilated adults in intensive care. The analysis included 11,946 participants from 39 trials and compared strategies such as nurse-driven protocols, daily sedation interruption, and sedative drug-choice regimens against usual care.

The primary outcome was ventilator-free days at day 28. The authors found that protocolised sedation and daily sedation interruption showed favourable effects versus usual care. In a 17-node network, the mean difference for protocolised sedation was 2.62 days (1.64 to 3.60) and for daily sedation interruption was 2.66 days (1.49 to 3.83). In a merged 5-node strategy network, the mean difference for protocolised sedation was 2.83 days (1.55 to 4.12) and for daily sedation interruption was 1.84 days (0.20 to 3.48).

The authors noted limitations, including variable risk of bias across trials and moderate to low confidence in some contrasts per CINeMA. Safety outcomes were not reported. The evidence base for no-sedation strategies was thinner.

Practice relevance is restrained; the authors suggest protocolised sedation and daily sedation interruption have the strongest combination of effect magnitude, reproducibility, and evidential credibility for improving ventilator-free days. Results indicate associations based on pooled data, not direct causation.

A new analysis of 39 randomized trials involving nearly 12,000 mechanically ventilated adults in intensive care suggests that certain nurse-implementable sedation strategies can improve outcomes. The study compared several approaches, including nurse-driven protocols, daily sedation interruption, and different drug choices, against usual care. The main focus was on how many days patients were alive and free from the ventilator by day 28.

The results showed that two strategies stood out: protocolised sedation and daily sedation interruption. Both were linked to about 2.5 more ventilator-free days compared with usual care. These findings come from a network meta-analysis, which pools data from many trials to compare multiple treatments at once. The researchers rated the evidence as moderately certain for these two strategies versus usual care.

However, the analysis had limitations. Most of the 39 trials had some concerns about bias, and only one was rated low risk. For some comparisons, the evidence was based on sparse or indirect data, making it less reliable. No safety information was reported in this analysis.

For patients and families, this means that simple, nurse-led changes to how sedation is managed may help reduce time on a ventilator. But the findings should be interpreted cautiously, as the quality of the underlying studies varies. Always discuss sedation plans with the ICU team.

What this means for you:
Nurse-led sedation protocols and daily sedation interruption may help ventilated ICU patients spend more days off the ventilator.

Study Details

Study typeMeta analysis
EvidenceLevel 1
PublishedMay 2026
View Original Abstract ↓
BackgroundSedation in mechanically ventilated adults is managed through bedside workflow strategies — such as nurse-driven protocols and daily sedation interruption — or through sedative drug-choice regimens. These interventions operate at different conceptual levels yet are often synthesised at inconsistent levels of granularity, risking inflated treatment hierarchies and obscured clinical applicability.MethodsWe analysed a harmonised dataset of 39 randomised trials (11,946 participants) using frequentist random-effects network meta-analysis. Reporting followed PRISMA 2020 and PRISMA-NMA, risk of bias was assessed with RoB 2, and certainty was graded with CINeMA. The primary outcome was ventilator-free days at day 28 (VFD28). Three prespecified analytical layers were applied: a 17-node intervention network, a merged 5-node strategy network, and a 4-node nurse-only subnetwork.ResultsDatabase and register searching yielded 5,581 records; after removal of 2,056 duplicates, 3,525 titles and abstracts were screened, 113 full reports were assessed, and 39 trials were retained in the final review. In the 17-node network, the numerically top-ranked node was a sparse oversedation-prevention threshold variant (OSP_P0.1), with an estimated mean difference of 4.62 VFD28 days versus usual care, but this estimate was entirely indirect and carried low credibility. The most reproducible gains were observed for daily sedation interruption (2.66 days, 1.49 to 3.83) and protocolised sedation (2.62 days, 1.64 to 3.60) versus usual care. In the merged 5-node strategy network, protocolised sedation remained favourable (2.83 days, 1.55 to 4.12), daily sedation interruption remained favourable (1.84 days, 0.20 to 3.48), and no-sedation favoured usual care (4.51 days, 1.60 to 7.42) but with a thinner evidence base. Restricting the analysis to nurse-implementable strategies preserved the direction of benefit, with protocolised sedation remaining the highest-ranked nursing strategy. Risk of bias was low in one trial, some concerns in 30, and high in eight. CINeMA indicated moderate confidence for protocolised sedation versus usual care and daily sedation interruption versus usual care, but low confidence for sparse or predominantly indirect contrasts.ConclusionProtocolised sedation and daily sedation interruption emerge as the two nurse-implementable strategies with the strongest combination of effect magnitude, reproducibility, and evidential credibility for improving ventilator-free days.Systematic review registrationhttps://www.crd.york.ac.uk/PROSPERO/view/CRD420261303518, CRD420261303518.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.